Sweat contains biomarkers that can monitor various health conditions, from diabetes to genetic disorders. Sweat sampling, unlike blood collection, is preferred by users due to its painless nature. However, to obtain sufficient nutrients or hormones from sweat for testing, intense physical activity was previously required to induce sweat. This method posed challenges for individuals with …
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the coronavirus disease 2019 (COVID-19), has been associated with the manifestation of adverse pulmonary conditions, such as pneumonia and acute respiratory distress syndrome (ARDS). A recent Nature Communications study identifies ferroptosis as a major cell death mechanism underlying COVID-19 lung disease. Study: Fatal COVID-19 pulmonary disease involves ferroptosis. Image Credit: Mang E / …
In a new paper, researchers from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine (“Insilico”), in collaboration with NVIDIA, present a new large language model (LLM) transformer for solving biological and chemical tasks called nach0. The multi-domain and multi-task LLM was trained on a diverse set of tasks, natural language understanding, synthetic route …
University of Virginia scientists have developed a new approach to machine learning – a form of artificial intelligence – to identify drugs that help minimize harmful scarring after a heart attack or other injuries. Jeff Saucerman, PhD. Image Credit: University of Virginia The new machine-learning tool has already found a promising candidate to help prevent …
Ghent University and the booming Ghent biotech landscape welcome a brand new spin-off: Amalus Therapeutics is developing a new class of drugs that selectively target corrupt fibroblast cells. This innovative approach offers the potential to greatly improve the prospects of patients with cancer or fibrotic diseases. The Belgian-Danish company is supported financially through BioInnovation Institute’s …
Guillaume Lassailly Credit: Research Gate Resolution of metabolic dysfunction-associated steatohepatitis (MASH) without worsening of patient fibrosis may be a reliable surrogate endpoint for bariatric surgery, according to new findings.1 In a first-of-its-kind trial presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases (AASLD) in Boston this weekend, a …